Balyasny Asset Management
ARNA

Balyasny Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Balyasny Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-116,200
Closed -$10.8M – 3046
2021
Q4 		$10.8M Buy
+116,200
New +$7.66M 0.04% 612
2018
Q3 		– Sell
-290,000
Closed -$12.6M – 2169
2018
Q2 		$12.6M Buy
290,000
+215,000
+287% +$9.24M 0.06% 418
2018
Q1 		$2.96M Buy
75,000
+25,000
+50% +$972K 0.01% 879
2017
Q4 		$1.7M Buy
+50,000
New +$1.42M 0.01% 1183

Balyasny Asset Management's ARNA Position: Q1 2022 in Review

Balyasny Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 245,191 shares — an estimated $22.8M sold.

Balyasny Asset Management first reported a position in ARNA in Q4 2016 and held it in 12 quarters. The position peaked at $42.4M in Q1 2018. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Balyasny Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 245,191 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $22.8M.
  • Balyasny Asset Management first reported a position in Arena Pharmaceuticals Inc in Q4 2016 and held it in 12 quarters.
  • Balyasny Asset Management's Arena Pharmaceuticals Inc position peaked at $42.4M in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Balyasny Asset Management's 13F filing for Q1 2022, filed 16 May 2022.